PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2013

(-)-Epigallocatechin-3-gallate (EGCG) modulates neurological function when intravenously infused in acute and, chronically injured spinal cord of adult rats.

Rat / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 24071567 ↗2013Reported benefit

(-)-Epigallocatechin-3-gallate (EGCG) modulates neurological function when intravenously infused in acute and, chronically injured spinal cord of adult rats.

RatSpinal cord injuryContusionSprague-DawleyFemalen = 72 adult female rats randomised across four treatment group…Intravenous infusionAcute group treated within the first 4 h after injury; chronic group treated on…

Model: Moderate thoracic contusion spinal cord injury using the MASCIS impactor

Intravenous EGCG infused for 36 h improved locomotor and sensory recovery and pain thresholds in both acute and one-year chronic injured rats, and reduced lesion size and increased neuronal numbers in the acute group.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.